Article Listing - Watson's Rapaflo approved by US FDA
FDA CRITERIA FOR PHARMACIES
17 February 1992
The US Food and Drug Administra-tion is close to issuing new criteria aimed at curbing the unauthorized manufacture of approved...
BIO-MERIEUX NEEDS NEW FINANCE
17 February 1992
The major French producer of in vitro diagnostic products, Bio-Merieux, plans to become one of the ten world diagnostic market...
OUTLOOK FOR FRENCH PHARMA STOCKS
17 February 1992
Although pricing of pharmaceutical products in France has lately been more favorable, it remains undeniably difficult, according to Baring Securities'...
US MARKET FOR FLU TREATMENTS
17 February 1992
The proliferation of flu remedies currently appearing on US drugstore shelves is more a product of marketing than medical breakthroughs,...
US GENERIC DRUG MARKET TO 1995
17 February 1992
The US market for generic drugs will more than double from a value of $5.5 billion in 1991 to reach...
GENZYME PRODUCES CFTR PROTEIN VIA MILK
17 February 1992
Genzyme Corp has announced that its researchers have developed the first genetically-engineered mice to produce in their milk a membrane...
PHILIPPINES DOUBT OVER CEPT SCHEME
17 February 1992
The pharmaceutical industry in the Philippines may not yet be strong enough to compete with the industries of the other...
DRUG APPROVAL CHANGE IN MALAYSIA
17 February 1992
At the end of 1991, the Drug Control Authority of the Malay- sian Ministry of Health implemented new procedures...
US FDA BANS COPIED ZALCITABINE
17 February 1992
The US Food and Drug Administra-tion has banned the sale of an unauthorized copy of Hoffmann-La Roche's AIDS therapy Hivid...
BIOCRAFT SETS SIGHTS ON GENERIC CECLOR
17 February 1992
At least one competitor has set its sights on capturing some of the market which will be left exposed when...
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
